Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Y Wen

Showing results (961-970 of 1,547) with videos related to

Pageof 155
Sort By:
Neuro-Oncology|August 19, 2024
Enhancing neuro-oncology care through equity-driven applications of artificial intelligenceMulki Mehari, Youssef Sibih, Abraham Dada, et al.
Neuro-Oncology|September 12, 2023
Brain tumor-related epilepsy management: A Society for Neuro-oncology (SNO) consensus review on current managementEdward K Avila, Steven Tobochnik, Sara K Inati, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 16, 2020
First-in-Human Phase I Study to Evaluate the Brain-Penetrant PI3K/mTOR Inhibitor GDC-0084 in Patients with Progressive or Recurrent High-Grade GliomaPatrick Y Wen, Timothy F Cloughesy, Alan G Olivero, et al.
Neuro-Oncology|October 21, 2020
A phase II study of dose-dense temozolomide and lapatinib for recurrent low-grade and anaplastic supratentorial, infratentorial, and spinal cord ependymomaMark R Gilbert, Ying Yuan, Jimin Wu, et al.
Archives of Pathology & Laboratory Medicine|January 8, 2021
Interobserver Variation of PD-L1 SP142 Immunohistochemistry Interpretation in Breast Carcinoma: A Study of 79 Cases Using Whole Slide ImagingRaza S Hoda, Edi Brogi, Timothy M D'Alfonso, et al.
Nature Medicine|August 20, 2013
Vessel architectural imaging identifies cancer patient responders to anti-angiogenic therapyKyrre E Emblem, Kim Mouridsen, Atle Bjornerud, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 10, 2020
Multiparametric MR-PET Imaging Predicts Pharmacokinetics and Clinical Response to GDC-0084 in Patients with Recurrent High-Grade GliomaBenjamin M Ellingson, Jingwen Yao, Catalina Raymond, et al.
Neuro-Oncology|March 6, 2024
ACTION: a randomized phase 3 study of ONC201 (dordaviprone) in patients with newly diagnosed H3 K27M-mutant diffuse gliomaIsabel Arrillaga-Romany, Andrew Lassman, Susan L McGovern, et al.
Neuro-Oncology|March 25, 2017
Leveraging molecular datasets for biomarker-based clinical trial design in glioblastomaShyam K Tanguturi, Lorenzo Trippa, Shakti H Ramkissoon, et al.
Journal of Animal Science|January 20, 2009
A whole genome scan for quantitative trait loci for leg weakness and its related traits in a large F2 intercross population between White Duroc and ErhualianY M Guo, H S Ai, J Ren, et al.
Pageof 155

Showing results (961-970 of 1,547) with videos related to

Sort By:
Pageof 155
Neuro-Oncology|August 19, 2024
Enhancing neuro-oncology care through equity-driven applications of artificial intelligenceMulki Mehari, Youssef Sibih, Abraham Dada, et al.
Neuro-Oncology|September 12, 2023
Brain tumor-related epilepsy management: A Society for Neuro-oncology (SNO) consensus review on current managementEdward K Avila, Steven Tobochnik, Sara K Inati, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 16, 2020
First-in-Human Phase I Study to Evaluate the Brain-Penetrant PI3K/mTOR Inhibitor GDC-0084 in Patients with Progressive or Recurrent High-Grade GliomaPatrick Y Wen, Timothy F Cloughesy, Alan G Olivero, et al.
Neuro-Oncology|October 21, 2020
A phase II study of dose-dense temozolomide and lapatinib for recurrent low-grade and anaplastic supratentorial, infratentorial, and spinal cord ependymomaMark R Gilbert, Ying Yuan, Jimin Wu, et al.
Archives of Pathology & Laboratory Medicine|January 8, 2021
Interobserver Variation of PD-L1 SP142 Immunohistochemistry Interpretation in Breast Carcinoma: A Study of 79 Cases Using Whole Slide ImagingRaza S Hoda, Edi Brogi, Timothy M D'Alfonso, et al.
Nature Medicine|August 20, 2013
Vessel architectural imaging identifies cancer patient responders to anti-angiogenic therapyKyrre E Emblem, Kim Mouridsen, Atle Bjornerud, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 10, 2020
Multiparametric MR-PET Imaging Predicts Pharmacokinetics and Clinical Response to GDC-0084 in Patients with Recurrent High-Grade GliomaBenjamin M Ellingson, Jingwen Yao, Catalina Raymond, et al.
Neuro-Oncology|March 6, 2024
ACTION: a randomized phase 3 study of ONC201 (dordaviprone) in patients with newly diagnosed H3 K27M-mutant diffuse gliomaIsabel Arrillaga-Romany, Andrew Lassman, Susan L McGovern, et al.
Neuro-Oncology|March 25, 2017
Leveraging molecular datasets for biomarker-based clinical trial design in glioblastomaShyam K Tanguturi, Lorenzo Trippa, Shakti H Ramkissoon, et al.
Journal of Animal Science|January 20, 2009
A whole genome scan for quantitative trait loci for leg weakness and its related traits in a large F2 intercross population between White Duroc and ErhualianY M Guo, H S Ai, J Ren, et al.
Pageof 155